Insulin-like growth factor 1 receptor signaling via Akt: a general therapeutic target in neurocutaneous melanocytosis?

Patel, Janki; Salgado, Cláudia M; Múgica, Miguel Reyes; Basu, Dipanjan

Patel, Janki; Salgado, Cláudia M; Múgica, Miguel Reyes; Basu, Dipanjan.

Afiliación

Patel J; Department of Pathology, Children's Hospital of Pittsburgh of UPMC and Dietrich School of Arts and Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania.
Salgado CM; Department of Pathology, Children's Hospital of Pittsburgh of UPMC and Dietrich School of Arts and Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania.
Múgica MR; Department of Pathology, Children's Hospital of Pittsburgh of UPMC and Dietrich School of Arts and Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania.
Basu D; Department of Pathology, Children's Hospital of Pittsburgh of UPMC and Dietrich School of Arts and Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania.

Neuro Oncol ; 18(1): 142-3, 2016 Jan.

Article en En | MEDLINE | ID: mdl-26667139

Asunto(s)

Antineoplásicos/administración & dosificación; Melanosis/tratamiento farmacológico; Melanosis/genética; Síndromes Neurocutáneos/tratamiento farmacológico; Síndromes Neurocutáneos/genética; Ensayos Antitumor por Modelo de Xenoinjerto/métodos; Animales; Humanos; Masculino

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Síndromes Neurocutáneos / Ensayos Antitumor por Modelo de Xenoinjerto / Melanosis / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Animals / Humans / Male Idioma: En Revista: Neuro Oncol Asunto de la revista: NEOPLASIAS / NEUROLOGIA Año: 2016 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google